AbbVie Inc. is 79.9x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($397.44 B vs $4.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LGND | ABBV |
|---|---|---|
| Market cap | $4.97 B | $397.44 B |
| US-listed rank | #1389 | #28 |
| Revenue (latest FY) | $268.09M | $61.16B |
| Net income (latest FY) | $124.45M | $4.23B |
| Net margin | 46.4% | 6.9% |
| P/E (trailing FY) | 40.0 | 94.0 |
| SEC filings | 2,226 | 1,008 |
AbbVie Inc. is 79.9x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($397.44 B vs $4.97 B).
In their latest fiscal years, LIGAND PHARMACEUTICALS INC reported $268.09M in revenue while AbbVie Inc. reported $61.16B.
Full pages: LIGAND PHARMACEUTICALS INC and AbbVie Inc., or browse the full rankings.